' I don't think it occurred to the investigators that this might be a relevant factor influencing the outcomes. '
Indeed, this was confirmed by Cade yesterday.
This is probably the first major trials (subject to validation) where this aspect has been identified. If so it is a major step forward in treating mCRC. And that is good news for the folks that suffer from this terrible disease.
Ann: Combined FOXFIRE Analysis Shows No Improvement in Survival, page-95
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.003(1.41%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $11.32K | 63.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6835717 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1404477 | 13 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |